CTRI Number |
CTRI/2022/05/042402 [Registered on: 06/05/2022] Trial Registered Prospectively |
Last Modified On: |
04/05/2022 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
A Clinical pilot study to evaluate effect of Nano Kanchanara Twak extract Capsule (Ayurvedic Medicine) in Hypothyroidism patients |
Scientific Title of Study
|
Experimental and Pilot Clinical Evaluation of safety and efficacy of Nano Kanchanara (Bauhinia variegata Linn) Twak Extract in Hypothyroidism |
Trial Acronym |
YCNKET |
Secondary IDs if Any
|
Secondary ID |
Identifier |
nil |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Yakshi Choudhary |
Designation |
Pg Scholar |
Affiliation |
Parul Institute Of Ayurved |
Address |
Opd no 116 dept of kayachikitsa parul ayurved hospital parul
university post limda tel waghodiya dist vadodara india
Vadodara GUJARAT 391760 India |
Phone |
7983254783 |
Fax |
|
Email |
yakshichoudhary@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Shailesh V Deshpande |
Designation |
Professor |
Affiliation |
Parul Institute Of Ayurved |
Address |
Opd no 116 dept of kayachikitsa parul ayurved hospital parul
university post limda tel waghodiya dist vadodara gujarat india
Vadodara GUJARAT 391760 India |
Phone |
9763104451 |
Fax |
|
Email |
dr.shaileshd@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Yakshi Choudhary |
Designation |
Pg Scholar |
Affiliation |
Parul Institute Of Ayurved |
Address |
Opd no 116 dept of kayachikitsa parul ayurved hospital parul
university post limda tel waghodiya dist vadodara gujarat india
Vadodara GUJARAT 391760 India |
Phone |
7983254783 |
Fax |
|
Email |
yakshichoudhary@gmail.com |
|
Source of Monetary or Material Support
|
Department of Kaychikitsa Parul Institute Of Ayurved Parul university |
|
Primary Sponsor
|
Name |
Dean Faculty Of Ayurved |
Address |
Parul institute of ayurved parul university Ap limda tel waghodiya dist vadodara gujarat india 391760 |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Yakshi Choudhary |
Parul Institute Of Ayurved |
Opd No 116 Dept of Kayachikitsa Parul ayurved hospital parul
university Post limda Tel waghodiya Dist Vadodara India 391760
Vadodara
GUJARAT
391760
India Vadodara GUJARAT |
7983254783
yakshichoudhary@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Parul Institute of ayurved-Institutional Ethics Committee for Human Research |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:E039||Hypothyroidism, unspecified. Ayurveda Condition: SVAYATHUH/SOTHAH/SOPAH, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Comparator Arm (Non Ayurveda) | | - | Tab Levothyroxine | Allopathic Medicine- Tab Levothyroxine | 2 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Nano Kanchnara Extract Capsule, Reference: Charak Samhita, Sutra Sthan, Annapanavidi adhyaya -27/104-105, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -Water), Additional Information: -Nano Kanchnara Extract Capsule is a herbal formulation contains nano Kanchanara extract powder | 3 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Nano Kanchnara Extract Capsule , Reference: Charak Samhita, Sutra Sthan, Annapanavidi adhyaya -27/104-105 , Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1500(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -Water), Additional Information: -Nano Kanchnara Extract Capsule is a herbal formulation contains nano Kanchanara extract powder. |
|
|
Inclusion Criteria
|
Age From |
20.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
1) Patients of either gender with age group 20-60 Years (both years inclusive)
2) Elevated level of serum TSH more than normal range (i.e. 0.4 -5.0 μIU/ml)
3) Patients having clinical features of hypothyroidism-
a. Puffiness of face and eyelids
b. Peripheral edema
c. Dry coarse skin
d. Breathlessness
e. Constipation
f. Weakness
g. Lethargy
h. Fatigue
i. Muscle ache
j. Menstrual abnormality
k. Hair loss |
|
ExclusionCriteria |
Details |
1)Known case of any chronic and severe systemic disorder including IHD, CVA, uncontrolled Hypertension, uncontrolled diabetes, CRF, Active Malignancy Disease
2)Pregnant and lactating females
3)Known case of congenital hypothyroidism and secondary hypothyroidism |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
An Open list of random numbers |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Effect on level of TSH value |
The efficacy of treatment will be assessed on the level of TSH value at baseline and at the end of 90 days |
|
Secondary Outcome
|
Outcome |
TimePoints |
1) Effect on subjective parameter on the basis of Billewicz Diagnostic Index and a standard gradation scale.
2) BMI
3) Lipid Profile
4) Hemogram |
The efficacy of treatment will be assessed on the basis of Billewicz Diagnostic Index and a standard gradation scale and BMI at baseline and at the end of 15 days till 90 days.
Lipid Profile, Hemogram will be assessed at baseline and at the end of 90 days |
|
Target Sample Size
|
Total Sample Size="12" Sample Size from India="12"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
12/05/2022 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
Nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Hypothyroidism is a hypo-metabolic clinical state
resulting from inadequate production of thyroid hormone for prolonged period or
rarely, from resistance of the peripheral tissue to the effect of thyroid
hormones. Primary hypothyroidism is a dysfunction in the thyroid gland and,
it can be sub-clinical or overt. Due to easily stimuli like stress and anxiety, the global incidence of hypothyroidism is increasing.
Kanchanara reduce the swelling of neck, increased serum thyroid hormone
concentration, decreased cholesterol and improve thyroid histology.
Kanchanara stem bark has been investigated and reported to
have anti-tumor property.
Kanchanara extract, as standardized extracts, provide unlimited opportunities
for uncovering new drug because of the innumerable availability of chemical composition.
Prevalence rate of Hypothyroidism in developed countries is 4.6% . Where as in
India it is 10.95%. Incidence rate of hypothyroidism is more in
females (15.86%) than males (5.02%).
Lacunas in current management. HRT is the single available treatment
& Long-term metabolic complications of HRT. Increased
dosage and continuous medication make the patient drug dependent till
the end of the life. So therefore need to find new drug which will
prevents further lacunas hence extraction of Kanchanar Twak will
help to concentrate the chemical constituent in a soluble form and by using Nanotechnology we will able to level up herbs bioavailability,
effectiveness and also able to reintroduce other component that were discarded
due to poor characteristics. |